Drainage of the Pleural Cavity and Chemical Pleurodesis for Malignant Pleural Effusion - Comparison of Bleomycin and Doxycycline

• Authors: Grzegorz Kacprzak , Jerzy Kołodziej
• Languages of publication: EN

Abstracts

EN

Malignant pleural effusion (MPE) may be an indication for palliative treatment to improve the quality of life and allow patients to leave the hospital. The most common treatment for MPE is drainage of the pleural cavity followed chemical pleurodesis.The aim of the study was to compare the efficacy of Bleomycin and Doxycycline for pleurodesis.Material and methods. Between 1996 and 2006, 105 patients (aged 30-84) were treated in the Wrocław Thoracic Surgery Centre for MPE using drainage of the pleural cavity followed by Bleomycin or Doxycycline for chemical pleurodesis. Lung cancer was diagnosed in 53 patients (49.5%), other malignancy in 49 patients (46.7%), and the primary focus was not established in 4 (3.8%) patients. Patients were divided into two groups: group I (n=56) consisted of patients who underwent pleurodesis with Bleomycin (60 mg), and group II (n=49) consisted of patients treated with Doxycycline (1 g or 0,5 g). Patients were divided into two subgroups. Subgroup A (n=31) included patients who died within the first month, and subgroup B (n=74) included patients who lived longer.Results. In subgroup A, total remission was achieved in 100% of group I - patients and 78.6% of group II - patients, respectively. There were no statistically significant differences (SSDs) between groups (p>0.05). In subgroup B, remission was analyzed after 1, 3, 6, and 9 months. Total remission after 9 months was achieved in 84.6% and 77.1% of patients in groups I and II, respectively. There were no statistical differences between groups. The median mean rate survival in groups I and II was 251 and 242 days, respectively (p>0.05). Drainage complications and side effects were analyzed.Conclusions. Better results were achieved following the use of Bleomycin than Doxycycline, but there were no SSDs between groups, nor were three any SSDs in survival length between groups. The most common side effect was pain, which occurred more frequently after treatment with Doxycycline than Bleomycin.

Keywords

EN

malignant pleural effusion; pleurodesis; pleural drainage; Doxycycline; Bleomycin

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2008
• Volume: 80
• Issue: 4
• Pages: 173-183

Dates

published

1 - 4 - 2008

online

10 - 5 - 2008

Contributors

author

Grzegorz Kacprzak

• Department of Thoracic Surgery, Medical University, Wrocław

author

Jerzy Kołodziej

• Department of Thoracic Surgery, Medical University, Wrocław

References

• Kacprzak G, Kołodziej J, Rzechonek A et al.: Management of malignant pleural effusion. W: Second International Congress of Thorax Surgery. June 24-26, 1998; Bologna, Italy. Editrice Compositori 1998; s. 325-330.
• Taubert J: Management of malignant pleural effusion. Nurs Clin North Am 2001; 36(4): 665-83.[PubMed]
• Lynch TJ: Management of Malignant Pleural Effusions. Chest 1993; 103(4): 385-89.
• Kacprzak G, Kołodziej J: Diagnostyka nowotworowego wysięku opłucnowego. Pol Przegl Chir 2003; 75(10): 1011-17.
• Kacprzak G, Kołodziej J: Sposoby postępowania u chorych z nowotworowym wysiękiem opłucnowym. Pol Przegl Chir 2003; 75(10): 1018-27.
• Ruckdeschel J: Management of malignant pleural effusion: an overview. Semin Oncol 1988; 15: 24-28.[PubMed]
• American Thoracic Society. Management of Malignant Pleural Effusions. Am J Respir Crit Care Med 2000; 162: 1987-2001.
• Antony VB, Loddenkemper R, Astoul P et al.: Management of malignant pleural effusions. Eur Respir J 2001; 18: 402-19.[Crossref][PubMed]
• Ruckdeschel JC, Moores D, Lee JY et al.: Intrapleural therapy for malignant pleural effusion. A randomized comparison of Bleomycin and Tetracycline. Chest 1991; 100(6): 1528-35.[Crossref][PubMed]
• Kacprzak G, Kołodziej J, Pawełczyk K i wsp.: Torakoskopia (wideotorakoskopia) w diagnostyce i leczeniu nowotworowego wysięku opłucnowego - doświadczenia własne. Pol Przegl Chir 2008; 80(1): 37-39.
• Schulze M, Boehle AS, Kurdow R et al.: D. Effective Treatment of Malignant Pleural Effusion by Minimal Invasive Thoracic Surgery: Thoracoscopic Talc Pleurodesis and Pleuroperitoneal Shunts in 101 Patients. Ann Thorac Surg 2001; 71: 1809-12.[PubMed][Crossref]
• Anderson CB, Philpott GW, Ferguson TB: The treatment of malignant pleural effusions. Cancer 1974; 33: 916-22.[Crossref][PubMed]
• Putnam JB, Light RW, Rodriguez RM et al.: A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86: 1992-9.
• Zaloznik AJ, Oswald SG, Langin M: Intrapleural Tetracycline in Malignant Pleural Effusions. A randomized study. Cancer 1983; 51: 752-55.[PubMed][Crossref]
• Morrison MC, Mueller PR, Lee MJ et al.: Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. A J R. 1992; 158(1): 41-43.
• Gust R, Kleine P, Fabel H: Fibrin glue and tetracycline pleurodesis in reccuring malignant pleural effusion - A randomized comparative study. Medizinische Klinik 1990; 85(1): 18-23.
• Landvater L, Hix WR, Mills M et al.: Malignant Pleural Effusion Treated by Tetracycline Sclerotherapy. A Comparison of Single vs Repated Instillation. Chest 1988; 93(6): 1196-98.[Crossref]
• Sugita T, Matsunaga K, Kobayashi H et al.: Intrapleural bleomycin for management of malignant pleural effusions. Gan To Kagaku Ryoho. 1995; 22(9): 1203-07.[PubMed]
• Ong KC, Indumathi V, Raghuram J et al.: A comparative study of pleurodesis using talc and bleomycin in the management of malignant pleural effusions. Respirology 2000; 5: 99-103.[Crossref][PubMed]
• Martinez-Moragon E, Aparicio J, Rogado MC et al.: Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J 1997; 10(10): 2380-83.[Crossref]
• Patz EF, McAdams HP, Erasmus JJ et al.: Sclerotherapy for malignant pleural effusions. A prospective randomized trial of Bleomycin vs Doxycycline with small-bore catheter drainage. Chest 1998; 113(5): 1305-11.
• Gravelyn TR, Michelson MK, Gross BH et al.: Tetracycline Pleurodesis for Malignant Pleural Effusions. A 10-Year Retrospective Study. Cancer 1987; 59: 1973-77.
• Belani CP, Einarson TR, Arikian SR et al.: Costeffectiveness analysis of available sclerosing agents used for pleurodesis in the management of malignant pleural effusion (MPE). Proc Ann Meet Am Soc Clin Oncol 1995; 14: A892-94.
• Cohen RG, Shely WW, Thompson SE et al.: Talc pleurodesis: talc slurry versus Thoracoscopic talc insufflation in a porcine model. Ann Thorac Surg 1996 62: 1000-04.[Crossref]
• Yim AP, Chan AT, Lee TW et al.: Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996 62: 1655-58[PubMed][Crossref]
• Zimmer PW, Hill M, Casey K et al.: Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997 112: 430-34.[PubMed][Crossref]
• Ong KC, Indumathi V, Raghuram J et al.: A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000 5: 9-103.
• Noppen M, Degreve J, Mignolet M et al.: A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions. Acta Clinica Belgica 1997 52: 258-62.[PubMed]

Identifiers

DOI

10.2478/v10035-008-0021-6